Skip to content
Awesome – Lifestyle
Author:
Resalis Therapeutics SRL
Resalis Therapeutics Announces First-in-Human Data for RES-010 Demonstrating Safety and Tolerability with Early Weight Loss Signals
November 5, 2026
Resalis Announces Initiation of Phase 1b Clinical Study Evaluating RES-010 as Treatment to Address Unmet Needs in Obesity
June 29, 2026